BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8100080)

  • 1. Neuroleptic-induced defecation in rats as a model for neuroleptic dysphoria.
    Sachdev P; Loneragan C; Westbrook F
    Psychiatry Res; 1993 Apr; 47(1):37-45. PubMed ID: 8100080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prolonged treatment with haloperidol on "emotional" defecation and movement in rats in a well-habituated environment.
    Sachdev P; Loneragan C; Westbrook F
    Psychiatry Res; 1994 Oct; 54(1):87-95. PubMed ID: 7701031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of specific dopamine D1 and D2 receptor antagonists and agonists and neuroleptic drugs on emotional defecation in a rat model of akathisia.
    Sachdev PS; Saharov T
    Psychiatry Res; 1998 Dec; 81(3):323-32. PubMed ID: 9925183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroleptic-induced emotional defecation: effects of pimozide and apomorphine.
    Sanberg PR
    Physiol Behav; 1989 Aug; 46(2):199-202. PubMed ID: 2602459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haloperidol-induced emotional defecation: a possible model for neuroleptic anxiety syndrome.
    Russell KH; Hagenmeyer-Houser SH; Sanberg PR
    Psychopharmacology (Berl); 1987; 91(1):45-9. PubMed ID: 2881319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of beta-adrenoceptor antagonists on a rat model of neuroleptic-induced akathisia.
    Sachdev PS; Saharov T
    Psychiatry Res; 1997 Sep; 72(2):133-40. PubMed ID: 9335204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic-induced emotional defecation: effects of scopolamine and haloperidol.
    Sanberg PR; Russell KH; Hagenmeyer-Houser SH; Giordano M; Zubrycki EM; Garver DL
    Psychopharmacology (Berl); 1989; 99(1):60-3. PubMed ID: 2506605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mecamylamine effects on haloperidol-induced catalepsy and defecation.
    Sanberg PR; Newman MB; Manresa JJ; Potts SE; Alvarez F; Cahill DW; Shytle RD
    Int J Neurosci; 2001 Jul; 109(1-2):81-90. PubMed ID: 11699343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat.
    Parashos SA; Barone P; Marin CA; Paraschos AJ; Kapitzoglou-Logothetis V; Chase TN
    Psychopharmacology (Berl); 1989; 98(2):189-92. PubMed ID: 2569216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The attenuating effect of carteolol hydrochloride, a beta-adrenoceptor antagonist, on neuroleptic-induced catalepsy in rats.
    Kikuchi T; Uwahodo Y; Tottori K; Nakai M; Morita S
    Psychopharmacology (Berl); 1997 May; 131(2):108-14. PubMed ID: 9201797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cocaine on multivariate locomotor behavior and defecation.
    Zubrycki EM; Giordano M; Sanberg PR
    Behav Brain Res; 1990 Jan; 36(1-2):155-9. PubMed ID: 2302315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.
    Weiner I; Shadach E; Barkai R; Feldon J
    Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
    Glenthøj B
    Psychopharmacology (Berl); 1993; 113(2):157-66. PubMed ID: 7855176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxic ventilatory response after dopamine D2 receptor blockade in unilateral rat model of Parkinson's disease.
    Andrzejewski K; Budzińska K; Zaremba M; Kaczyńska K
    Neuroscience; 2016 Mar; 316():192-200. PubMed ID: 26705738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic-induced supersensitivity and brain iron: I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivity.
    Ben-Shachar D; Youdim MB
    J Neurochem; 1990 Apr; 54(4):1136-41. PubMed ID: 1968955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
    Haleem DJ; Samad N; Haleem MA
    Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Domperidone stimulates prolactin secretion in rats with complete destruction of the mediobasal hypothalamus.
    Kiem DT; Nagy GM; Barna I; Makara GB
    Brain Res Bull; 1997; 44(2):151-4. PubMed ID: 9292204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorpromazine, haloperidol, metoclopramide and domperidone release prolactin through dopamine antagonism at low concentrations but paradoxically inhibit prolactin release at high concentrations.
    Besser GM; Delitala G; Grossman A; Stubbs WA; Yeo T
    Br J Pharmacol; 1980; 71(2):569-73. PubMed ID: 6110459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS; Kulkarni SK
    Eur J Pharmacol; 2001 Sep; 428(1):81-6. PubMed ID: 11779040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine increases cutaneous blood flow and reduces sympathetic cutaneous vasomotor alerting responses (SCVARs) in rats: comparison with effects of haloperidol.
    Blessing WW
    Psychopharmacology (Berl); 2005 Sep; 181(3):518-28. PubMed ID: 15986198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.